Design and implement advanced de-risking methods and workflows to assess alloreactivity, unintended HLA interactions, off-target toxicity risk including X-scan, peptide library screens and library-on-library HTS. The Assistant Lead, TCR Discovery, is responsible for supporting the development of a rigorous, high‑throughput discovery and preclinical development engine that identifies high throughput and with high confidence tumor-specific TCRs for downstream analysis, engineering, and translational development.